icon-folder.gif   Conference Reports for NATAP  
 
  International Workshop on HIV & Hepatitis Virus Drug Resistance
5-9 June 2012, Sitges, Spain
Back grey_arrow_rt.gif
 
 
 
Deep sequencing analysis of rilpivirine virologic failures in the Phase III studies ECHO and THRIVE shows no association with the presence of minority resistance associated variants at baseline (part II)
 
 
  Reported by Jules Levin
Intl Resistance Workshop, Sitges Spain June 5-9 2012
 
V Van Eygen1, K Thys1, J Vingerhoets1, C Van Hove2, LT Rimsky1, J Aerssens1 and GR Picchio3
 
1Janssen Infectious Diseases, Beerse, Belgium; 2Janssen Pharmaceutica, Beerse, Belgium; 3Janssen R&D Inc, Titusville, NJ, USA

resistance1.gif

resistance2.gif

resistance3.gif

resistance4.gif

resistance5.gif

resistance6.gif

resistance7.gif